Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equipment and medicines, etc. It also provides pet healthcare and livestock products, such as medical supplies, nutrition therapy, vaccine, supplementary food, probiotic and prebiotic products, animal health food products, animal food, general formula animal food, nutraceuticals and medicine companion products, ear and teeth cleaners, pee pads, shampoos, and medical equipment related to pet and livestock care product, etc. In addition, the company provides care and treatment for patients with general and specialized diseases, such as cardiovascular disease, bone and joint disease, neuropathy, medical diseases, surgical diseases, kidney disease, obstetrics and gynecology, ear, eye, nose, throat diseases, blood diseases, pediatric clinics, etc. It serves retail customers through distributors. The company was incorporated in 2006 and is headquartered in Bangkok, Thailand.
Metrics to compare | IP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIPPeersSector | |
---|---|---|---|---|
P/E Ratio | 59.1x | 10.0x | 11.5x | |
PEG Ratio | −2.26 | 0.03 | 0.03 | |
Price/Book | 1.1x | 0.8x | 1.5x | |
Price / LTM Sales | 1.2x | 1.1x | 0.9x | |
Upside (Analyst Target) | 182.7% | 44.7% | 21.8% | |
Fair Value Upside | Unlock | 33.2% | 12.2% | Unlock |